The global search for disease-modifying treatments capable of halting or reversing neurodegenerative conditions stands as one of the most demanding challenges in contemporary biomedicine. Among these complex pathologies, Alzheimer’s disease represents a devastating progressive disorder characterized by extensive synaptic loss, chronic neuroinflammation, abnormal protein aggregation, and the steady deterioration of cognitive function. While conventional pharmaceutical […]